FDA guidance updates postmarket surveillance program

08/18/2011 | MassDevice.com (Boston)

The FDA has issued guidance outlining the types of devices that may be eligible for postmarket surveillance as well as how manufacturers should comply with the program. The guidance, which will be up for comment over the next three months, also recommends that the 36-month surveillance period be extended for pediatric devices.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD